Searched for
GRANULES PHARMACEUTICALS INC
Granules India gets USFDA tentative nod for generic ADHD treatment tabletsGranules Pharmaceuticals, Inc., a subsidiary of Granules India, has achieved a significant milestone with the tentative green light from US...- Granules unit gets USFDA nod for generic drugGranules India has secured tentative approval from the USFDA for its generic ADHD medication. This approval is for Amphetamine extended-rel...
- Granules India recalls 33,000 bottles of blood lowering medication in USGranules India is recalling over 33,000 bottles of Metoprolol Succinate, a generic blood pressure medication, in the US due to manufacturin...
- Granules India gets USFDA nod for generic drugGranules Pharmaceuticals, Inc. secured USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets. The tablets treat ADHD in c...
- Granules India gets USFDA nod for generic Glycopyrrolate oral solutionGranules Pharmaceuticals Inc, a subsidiary of Granules India, has received approval from the USFDA for a generic Glycopyrrolate oral soluti...
- Finally out of the woods? 4 small and midcap pharma stocks with an upside potential of up to 26%Pharma as a sector has been under pressure for a very long time. Some time USFDA issues, at other instances of pricing pressure in US marke...
- Granules gets USFDA's nod for Amphetamine capsulesAmphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. T...
- USFDA issues 3 minor observations to Granules India arm in pre-approval inspectionCommenting on the audit, GPI Executive Director Priyanka Chigurupati said, "We are glad to have completed yet another audit with minor obse...
- Granules India gets USFDA nod for generic Prazosin Hydrochloride capsulesThe US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals...
- Drug makers Granules India, Jubilant Cadista recall products in US marketSalisbury-based Jubilant Cadista Pharmaceuticals Inc is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of Noida-based Ju...
- Granules India gets Health Canada nod to market arthritis tabletsThe drug will be manufactured at the company's manufacturing facility located in Gagillapur, Hyderabad, the filing said.
- Granules arm gets American health regulator's nod for Potassium Chloride Oral SolutionIn a BSE filing, Granules said the US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed b...
- Granules India rises 3% on USFDA nod to insomnia drugThe company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine capsulesButalbital, Acetaminophen and Caffeine Capsules are used to treat tension headaches. Butalbital, Acetaminophen and Caffeine Capsules USP, 5...
- Granules' US unit gets two USFDA observationsAs per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any condit...
- Granules' arm completes audit with USFDAGranules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company completed its first audit from December 4-8, 2017 by the USF...
- Granules India Q1 net profit rises by 37% to Rs 39 croreOperating margin improved by 96 basis points to 20.8 per cent from 19.9 per cent and net profit margin by 249 basis points to 11.3 per cent...
- Granules to acquire 12.5 per cent stake in USpharmaUSpharma is a development-stage pharmaceutical company specialising in research, development and manufacture of high entry-barrier generic ...
- Granules acquires rights for 4 products from USpharma WindlasGranules said it will be responsible for the marketing and distribution of the products in the US, subject to the final approval by the US ...
Load More
